Radius Health Gets $43M to Push Osteo Injection, Patch
By Randy Osborne
Friday, April 26, 2013
Radius Health Inc.'s new equity cash of $43 million will go toward further work with its anabolic bone builder BA058, in Phase III trials as an injectable therapy and Phase II as a "short-wear" patch.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.